Biotech Advances Offer Promises to Consumers and Challenges to Health Plans: 'Health Affairs' Case Study.Scientific Base, Fairness and Collaboration Are Keys to Success; Premera Blue Cross Premera Blue Cross is a nonprofit Blue Cross Blue Shield licensed health insurance company based in Mountlake Terrace, Washington. It sells health insurance plans under the Blue Cross license in Washington state except Clark County and under both the Blue Cross and Blue Shield Pharmaceutical Team Collaborates with UW Professor MOUNTLAKE TERRACE Mountlake Terrace, city (1990 pop. 19,320), Snohomish co., NW Wash., a residential suburb of Seattle; inc. 1954. Its manufactures include refrigeration systems and communications equipment. , Wash. -- Each week the media report to consumers the potential health benefits of the latest advances by biotechnology researchers; however, those same potential advances hold great challenges to health insurers that are being addressed by Premera Blue Cross, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. a case study ("Managing Biotechnology In A Network-Model Health Plan: A U.S. Private Payer Perspective") published in the current issue of the journal "Health Affairs" by member of Premera's pharmaceutical units and a University of Washington professor of pharmacy and public health. "Medicine today and biotechnology, in particular, offers us as patients such great promise of being able to treat diseases and conditions that only a relatively few years ago were untreatable Un`treat´a`ble a. 1. Incapable of being treated; not practicable. ," said lead author John Watkins John Watkins could be any of the following:
BCPS Board Certified Pharmacotherapy Specialist (pharmacist certificate) BCPS Broward County Public Schools (Florida) , pharmacy manager in Premera's Formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions. National Formulary see under N. for·mu·lar·y n. Development. "Health plans must work ahead of the curve as much as possible by developing and implementing a formulary that is scientifically sound, fair to patients and cost-effective." The case study in the renowned health-policy journal tracks how Premera developed an "integrated cross-functional approach to managing biologics, built around a robust formulary process." According to the four authors, Premera monitored the results from merged pharmacy and medical claims. Using an integrated approach that had full support by senior management, Premera chose to manage their response to biologics internally rather than outsource the project like many health insurers do. "Premera's reputation with physicians and other healthcare providers throughout Washington dictated that we approach biologics with the same collaborative commitment that we have historically approached quality of care issues for our members," said Ed Wong, Pharm.D., BCPS, FASHP FASHP Fellow of the American Society of Health System Pharmacists and Premera pharmacy director, referring to Premera's groundbreaking collaborative Quality Score Card program. "Given our existing collaborative relationships with medical groups and our existing scientific evidence-based formulary process, we believed that managing the program ourselves was the only logical and acceptable option." According to the case study, Premera established a Biotechnology Task Force that utilized services of more than 75 Premera staff members divided into eight work groups - three of which are still operational. The launch of the company's three phase program began in 2003. The first phase focused on assessing the magnitude of the situation. Phase II targeted technology assessment, patient and provider assessment and collaboration and benefits assessment. The third phase was the implementation which began in August, 2004. "Our next challenge is genomics which not only opens the potential for 'personalized medicine,' but will also add a maze of ethical considerations," said Dr. Wong. Premera has already begun consultations with a range of ethicists in preparation for this next challenge. In addition to Watkins and Dr. Wong, the report was authored by Sanchita Roy Choudhury, PhD, pharmacy program coordinator and senior internal consultant in Premera's Pharmacy Services, and Sean Sullivan, PhD, professor of pharmacy & public health and director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington. Dr. Wong is also a clinical professor of pharmacy at UW. Watkins is a clinical associate professor of pharmacy at UW. About Premera Blue Cross Our mission is to provide peace of mind to our members about their health-care coverage. We provide health insurance and related services to more than 1.3 million people. Premera Blue Cross has operated in Washington since 1933 and Alaska since 1957. Premera Blue Cross is an independent licensee of the Blue Cross Blue Shield Blue Shield A US not-for-profit health care insurer that is a reimbursement intermediary for physicians. Cf Blue Cross. Association. Premera Blue Cross is a member of a family of companies based in Mountlake Terrace, Washington Mountlake Terrace is a city in Snohomish County, Washington, United States. The population was 20,362 at the 2000 census. History Mountlake Terrace was officially incorporated on November 30, 1954. , that provide health, life, vision, dental, and long-term care long-term care (LTC), n the provision of medical, social, and personal care services on a recurring or continuing basis to persons with chronic physical or mental disorders. insurance, and other related services. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion